EUVIMEDEUVIMED entdecken
Crossref

Vaccine Development and Testing

Robert M Seiser

QUBES · 01.01.2023

DOI: 10.25334/vv2g-mz30 ↗

Kurz gefasst

Fachartikel in der Zeitschrift QUBES, erschienen am 01.01.2023. Verfasst von Robert M Seiser.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Scientists have the tools and knowledge to develop safe, effective vaccines, from trials to vials. This resource addresses the process by which vaccines are designed, tested and regulated. Key concepts include 1. Mechanisms of immune recognition for SARS CoV 2 2. Vaccines vs therapeutics 3. Vaccine types and sources - nucleic acid, viral vector and attenuated/inactive vaccines 4. Vaccine development pipeline 5. Exploratory research and vaccine design for SARS-CoV-2 - spike protein target 6. Vaccine production 7. Testing and clinical trials 8. Challenge trials 9. Regulatory review and approval

Schlagwörter

vaccine developmentvaccine testingSARS-CoV-2COVID-19 vaccinesimmune recognitionspike proteinnucleic acid vaccinesviral vector vaccineslive attenuated vaccinevaccine design

Zitieren

APA

Seiser, R. M. (2023). Vaccine Development and Testing. QUBES. https://doi.org/10.25334/vv2g-mz30

Vancouver

Seiser RM. Vaccine Development and Testing. QUBES. 2023. doi:10.25334/vv2g-mz30

BibTeX
@article{Seiser2023,
  author = {Seiser, Robert M},
  title = {Vaccine Development and Testing},
  journal = {QUBES},
  year = {2023},
  doi = {10.25334/vv2g-mz30}
}
Kostenlos starten →